(KLAC) KLA-Tencor - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4824801009
Stock: Inspection, Metrology, Software, Etch, Deposition
Total Rating 85
Risk 89
Buy Signal 1.10
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.86% |
| Yield on Cost 5y | 2.67% |
| Yield CAGR 5y | 17.37% |
| Payout Consistency | 93.5% |
| Payout Ratio | 21.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 44.5% |
| Relative Tail Risk | -6.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.08 |
| Alpha | 116.77 |
| Character TTM | |
|---|---|
| Beta | 1.730 |
| Beta Downside | 1.611 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.95% |
| CAGR/Max DD | 1.77 |
Description: KLAC KLA-Tencor January 27, 2026
KLA Corporation (NASDAQ:KLAC) designs, manufactures, and markets process-control and yield-management solutions for the semiconductor and related electronics industries. It operates through three segments-Semiconductor Process Control, Specialty Semiconductor Process, and PCB & Component Inspection-offering tools for defect inspection, metrology, chemical process control, and software that accelerates yield learning and reduces production risk.
In FY 2023 the company generated $9.3 billion in revenue, up 12% year-over-year, driven by strong demand for advanced-node inspection equipment as AI-chip and 3-nm fabs ramp. Gross margin expanded to 53% (vs. 50% in FY 2022) reflecting pricing power in a market where global semiconductor equipment spend is projected to grow 9% CAGR through 2027, according to SEMI. Capital expenditures rose to $1.1 billion, underscoring KLA’s investment in next-generation imaging and AI-enabled metrology platforms.
For a deeper quantitative assessment, see ValueRay’s detailed KLAC model.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 4.24b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.24 > 0.02 and ΔFCF/TA 3.66 > 1.0 |
| NWC/Revenue: 54.70% < 20% (prev 52.98%; Δ 1.72% < -1%) |
| CFO/TA 0.26 > 3% & CFO 4.25b > Net Income 4.24b |
| Net Debt (4.14b) to EBITDA (5.56b): 0.74 < 3 |
| Current Ratio: 2.69 > 1.5 & < 3 |
| Outstanding Shares: last quarter (132.4m) vs 12m ago -1.84% < -2% |
| Gross Margin: 61.62% > 18% (prev 0.60%; Δ 6101 % > 0.5%) |
| Asset Turnover: 78.28% > 50% (prev 65.36%; Δ 12.92% > 0%) |
| Interest Coverage Ratio: 17.75 > 6 (EBITDA TTM 5.56b / Interest Expense TTM 291.1m) |
Altman Z'' 5.88
| A: 0.42 (Total Current Assets 10.90b - Total Current Liabilities 4.05b) / Total Assets 16.32b |
| B: 0.15 (Retained Earnings 2.50b / Total Assets 16.32b) |
| C: 0.32 (EBIT TTM 5.17b / Avg Total Assets 16.00b) |
| D: 0.44 (Book Value of Equity 4.99b / Total Liabilities 11.33b) |
| Altman-Z'' Score: 5.88 = AAA |
Beneish M -2.93
| DSRI: 0.97 (Receivables 2.46b/2.08b, Revenue 12.52b/10.25b) |
| GMI: 0.98 (GM 61.62% / 60.38%) |
| AQI: 0.97 (AQ_t 0.25 / AQ_t-1 0.26) |
| SGI: 1.22 (Revenue 12.52b / 10.25b) |
| TATA: -0.00 (NI 4.24b - CFO 4.25b) / TA 16.32b) |
| Beneish M-Score: -2.93 (Cap -4..+1) = A |
What is the price of KLAC shares?
As of January 30, 2026, the stock is trading at USD 1684.71 with a total of 1,504,615 shares traded.
Over the past week, the price has changed by +12.31%, over one month by +33.67%, over three months by +36.61% and over the past year by +138.31%.
Over the past week, the price has changed by +12.31%, over one month by +33.67%, over three months by +36.61% and over the past year by +138.31%.
Is KLAC a buy, sell or hold?
KLA-Tencor has received a consensus analysts rating of 3.96.
Therefore, it is recommended to buy KLAC.
- StrongBuy: 11
- Buy: 6
- Hold: 10
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KLAC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1477.4 | -12.3% |
| Analysts Target Price | 1477.4 | -12.3% |
| ValueRay Target Price | 2628 | 56% |
KLAC Fundamental Data Overview January 24, 2026
P/E Trailing = 47.8439
P/E Forward = 41.3223
P/S = 15.7715
P/B = 39.5357
P/EG = 2.8346
Revenue TTM = 12.52b USD
EBIT TTM = 5.17b USD
EBITDA TTM = 5.56b USD
Long Term Debt = 5.89b USD (from longTermDebt, last quarter)
Short Term Debt = 46.8m USD (from shortTermDebt, last quarter)
Debt = 6.09b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.14b USD (from netDebt column, last quarter)
Enterprise Value = 201.57b USD (200.16b + Debt 6.09b - CCE 4.68b)
Interest Coverage Ratio = 17.75 (Ebit TTM 5.17b / Interest Expense TTM 291.1m)
EV/FCF = 52.02x (Enterprise Value 201.57b / FCF TTM 3.87b)
FCF Yield = 1.92% (FCF TTM 3.87b / Enterprise Value 201.57b)
FCF Margin = 30.94% (FCF TTM 3.87b / Revenue TTM 12.52b)
Net Margin = 33.83% (Net Income TTM 4.24b / Revenue TTM 12.52b)
Gross Margin = 61.62% ((Revenue TTM 12.52b - Cost of Revenue TTM 4.81b) / Revenue TTM)
Gross Margin QoQ = 61.27% (prev 63.24%)
Tobins Q-Ratio = 12.35 (Enterprise Value 201.57b / Total Assets 16.32b)
Interest Expense / Debt = 1.17% (Interest Expense 71.1m / Debt 6.09b)
Taxrate = 14.39% (188.4m / 1.31b)
NOPAT = 4.42b (EBIT 5.17b * (1 - 14.39%))
Current Ratio = 2.69 (Total Current Assets 10.90b / Total Current Liabilities 4.05b)
Debt / Equity = 1.22 (Debt 6.09b / totalStockholderEquity, last quarter 4.99b)
Debt / EBITDA = 0.74 (Net Debt 4.14b / EBITDA 5.56b)
Debt / FCF = 1.07 (Net Debt 4.14b / FCF TTM 3.87b)
Total Stockholder Equity = 4.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 26.48% (Net Income 4.24b / Total Assets 16.32b)
RoE = 98.15% (Net Income TTM 4.24b / Total Stockholder Equity 4.32b)
RoCE = 50.64% (EBIT 5.17b / Capital Employed (Equity 4.32b + L.T.Debt 5.89b))
RoIC = 43.36% (NOPAT 4.42b / Invested Capital 10.20b)
WACC = 11.96% (E(200.16b)/V(206.25b) * Re(12.29%) + D(6.09b)/V(206.25b) * Rd(1.17%) * (1-Tc(0.14)))
Discount Rate = 12.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.43%
[DCF Debug] Terminal Value 68.94% ; FCFF base≈3.58b ; Y1≈4.30b ; Y5≈6.87b
Fair Price DCF = 458.2 (EV 64.35b - Net Debt 4.14b = Equity 60.21b / Shares 131.4m; r=11.96% [WACC]; 5y FCF grow 21.32% → 2.90% )
EPS Correlation: -21.59 | EPS CAGR: -44.41% | SUE: -4.0 | # QB: 0
Revenue Correlation: 70.47 | Revenue CAGR: 8.64% | SUE: 1.10 | # QB: 5
EPS next Quarter (2026-03-31): EPS=8.95 | Chg30d=+0.070 | Revisions Net=+1 | Analysts=24
EPS current Year (2026-06-30): EPS=36.00 | Chg30d=+0.173 | Revisions Net=+6 | Growth EPS=+8.2% | Growth Revenue=+8.2%
EPS next Year (2027-06-30): EPS=43.93 | Chg30d=+1.812 | Revisions Net=+4 | Growth EPS=+22.0% | Growth Revenue=+15.5%
P/E Forward = 41.3223
P/S = 15.7715
P/B = 39.5357
P/EG = 2.8346
Revenue TTM = 12.52b USD
EBIT TTM = 5.17b USD
EBITDA TTM = 5.56b USD
Long Term Debt = 5.89b USD (from longTermDebt, last quarter)
Short Term Debt = 46.8m USD (from shortTermDebt, last quarter)
Debt = 6.09b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.14b USD (from netDebt column, last quarter)
Enterprise Value = 201.57b USD (200.16b + Debt 6.09b - CCE 4.68b)
Interest Coverage Ratio = 17.75 (Ebit TTM 5.17b / Interest Expense TTM 291.1m)
EV/FCF = 52.02x (Enterprise Value 201.57b / FCF TTM 3.87b)
FCF Yield = 1.92% (FCF TTM 3.87b / Enterprise Value 201.57b)
FCF Margin = 30.94% (FCF TTM 3.87b / Revenue TTM 12.52b)
Net Margin = 33.83% (Net Income TTM 4.24b / Revenue TTM 12.52b)
Gross Margin = 61.62% ((Revenue TTM 12.52b - Cost of Revenue TTM 4.81b) / Revenue TTM)
Gross Margin QoQ = 61.27% (prev 63.24%)
Tobins Q-Ratio = 12.35 (Enterprise Value 201.57b / Total Assets 16.32b)
Interest Expense / Debt = 1.17% (Interest Expense 71.1m / Debt 6.09b)
Taxrate = 14.39% (188.4m / 1.31b)
NOPAT = 4.42b (EBIT 5.17b * (1 - 14.39%))
Current Ratio = 2.69 (Total Current Assets 10.90b / Total Current Liabilities 4.05b)
Debt / Equity = 1.22 (Debt 6.09b / totalStockholderEquity, last quarter 4.99b)
Debt / EBITDA = 0.74 (Net Debt 4.14b / EBITDA 5.56b)
Debt / FCF = 1.07 (Net Debt 4.14b / FCF TTM 3.87b)
Total Stockholder Equity = 4.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 26.48% (Net Income 4.24b / Total Assets 16.32b)
RoE = 98.15% (Net Income TTM 4.24b / Total Stockholder Equity 4.32b)
RoCE = 50.64% (EBIT 5.17b / Capital Employed (Equity 4.32b + L.T.Debt 5.89b))
RoIC = 43.36% (NOPAT 4.42b / Invested Capital 10.20b)
WACC = 11.96% (E(200.16b)/V(206.25b) * Re(12.29%) + D(6.09b)/V(206.25b) * Rd(1.17%) * (1-Tc(0.14)))
Discount Rate = 12.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.43%
[DCF Debug] Terminal Value 68.94% ; FCFF base≈3.58b ; Y1≈4.30b ; Y5≈6.87b
Fair Price DCF = 458.2 (EV 64.35b - Net Debt 4.14b = Equity 60.21b / Shares 131.4m; r=11.96% [WACC]; 5y FCF grow 21.32% → 2.90% )
EPS Correlation: -21.59 | EPS CAGR: -44.41% | SUE: -4.0 | # QB: 0
Revenue Correlation: 70.47 | Revenue CAGR: 8.64% | SUE: 1.10 | # QB: 5
EPS next Quarter (2026-03-31): EPS=8.95 | Chg30d=+0.070 | Revisions Net=+1 | Analysts=24
EPS current Year (2026-06-30): EPS=36.00 | Chg30d=+0.173 | Revisions Net=+6 | Growth EPS=+8.2% | Growth Revenue=+8.2%
EPS next Year (2027-06-30): EPS=43.93 | Chg30d=+1.812 | Revisions Net=+4 | Growth EPS=+22.0% | Growth Revenue=+15.5%